SB-121

N/A

Report date: 2022/12/29 15:52:01

Base Information

Drug NameSB-121
Drug Alias NameSB-121
ClassificationNatural product/Extract > Microbial extract
Mechanisms of ActionBacteria replacementsMicrobiome modulators
TargetsNot applicable
Therapy Area/IndicationsAutistic Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesScioto Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesGenome & CompanyScioto Biosciences Inc
Inactive CompaniesN/A
Active IndicationsAutistic Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A